Ed is a Patent Attorney in the Biotechnology team.
He joined Dehns in 2015 upon the completion of a PhD in molecular microbiology from Imperial College London. Prior to his PhD, he graduated from Oxford University in 2010 with a first class degree in Biochemistry. Ed handles patent work in a range of biotechnology fields.
Ed qualified as a UK and European Patent Attorney in 2021.
Ed works with a variety of clients types, from universities to start-ups, spin-outs and SMEs all the way through to multinational corporations.
He provides patentability advice, drafts new patent applications, and prosecutes applications to grant before the European Patent Office; he also handles international patent portfolios. He also has experience of handling both offensive and defensive oppositions before the European Patent Office.
Ed’s scientific expertise involves handling patents in a wide variety of biotechnology and pharmaceutical fields, including: therapeutic inventions (small molecules, immunotherapies, treatments for cancer, infectious diseases, etc.), vaccines, diagnostic methods, recombinant plants, biotechnology processes (e.g. biofuel production) and industrial enzymes.
PhD, Molecular Microbiology, Imperial College London, 2015
MBiochem (First Class), Molecular and Cellular Biochemistry, University of Oxford, 2010
Ed’s PhD focused on putative virulence factors in Clostridium difficile and Clostridium sordellii, in particular their Type IV Pili. He authored or co-authored a number of academic papers in this field.